(Provides element, background)

LONDON, July 12 (Reuters) – Medicinal cannabis producer Freyherr Worldwide Group plans to checklist on the NEX alternate in London, it mentioned on Friday, as firms look to use growing legalisation of the plant.

A rising variety of nations in Europe have legalised or are planning to legalise cannabis for medicinal use, together with Britain and Germany.

Some U.S. states have additionally legalised marijuana for medicinal use, whereas Canada legalised leisure cannabis final 12 months.

Freyherr Worldwide is the UK mum or dad of a primarily Slovenian-based firm which grows cannabis and manufactures cannabis-derived concentrates and extracts.

One of many first cannabis producers to checklist in London, Freyherr will apply for admission to buying and selling on the NEX Progress Market, with the primary day of buying and selling anticipated to be July 30, it mentioned in a press release.

Sativa Group, additionally listed on NEX, is an funding automobile specializing in the medicinal cannabis sector in Canada.

The Freyherr providing consists of two.53 million abnormal shares out there for subscription, representing round 10% of the corporate’s share capital.

Freyherr mentioned it could use the proceeds for facility upgrades and new gear. It operates primarily within the European Union.

By 2028, the European cannabis market may very well be price as much as 123 billion euros, in accordance with market intelligence agency Prohibition Companions.

Reporting by Carolyn Cohn; Enhancing by Mark Potter and David
Evans

Our Requirements:The Thomson Reuters Belief Rules.